Corvex, Inc. Form 10-K/A Amendment No. 1: Detailed Investor Report

Corvex, Inc. has issued Amendment No. 1 to its Annual Report for the fiscal year ended December 31, 2025, filed originally on March 31, 2026. This amended filing provides critical updates and restates key sections related to corporate governance, executive compensation, security ownership, related transactions, and principal accountant fees. Below, we detail the most important aspects for shareholders, including items that may impact share value.

Key Points in the Amended Report

• Restatement of Part III Items: The amendment fully restates Items 10 (Directors, Executive Officers and Corporate Governance), 11 (Executive Compensation), 12 (Security Ownership), 13 (Related Transactions and Director Independence), and 14 (Accountant Fees).
• No Documents Incorporated by Reference: The cover page now reflects that no documents are incorporated by reference into this annual report, which may affect how investors and analysts review the filing.
• New Certifications Filed: New certifications of the principal executive and financial officers under Rule 13a-14(a) are included, along with the Company’s 2024 Equity Incentive Plan and an updated description of common stock as exhibits.
• No Financial Statements in Amendment: No financial statements are included or amended in this filing, and certifications under Section 906 of the Sarbanes-Oxley Act are omitted.

Details Shareholders Must Know

• Common Stock Structure: Corvex, Inc. is authorized to issue up to 500,000,000 shares of Common Stock with currently 1,981,462 shares outstanding. Each share entitles the holder to one vote. There is no cumulative voting.
• Preferred Stock: The company can issue up to 50,000,000 shares of preferred stock in one or more series, with terms set by the board. Currently, several series of preferred stock are outstanding, including Series A, C, and D Non-Voting Convertible Preferred Stock.
• Anti-Takeover Provisions: The Certificate of Incorporation and Bylaws include provisions to discourage, delay, or prevent a change in control, such as the ability to issue authorized but unissued shares without shareholder approval, staggered board terms, and advance notice for director nominations.
• Equity Incentive Plan: The 2024 Equity Incentive Plan allows for up to 2,295,000 shares to be issued as stock awards. Outstanding equity awards, as of December 31, 2025, include 132,869 shares under approved plans and 2,316 shares under non-approved plans.
• Insider Trading Policy: The company has adopted and filed an Insider Trading Policy, prohibiting directors, officers, employees, and consultants (and their immediate family members) from engaging in transactions involving puts, calls, or derivatives related to Corvex securities.
• Delayed Section 16(a) Filings: Several directors were late in filing Form 4s due to administrative errors, specifically relating to changes in the Director Equity Program. Such issues could be viewed as governance risks by investors.
• Executive Compensation: Details of option awards, including exercise prices and expiration dates, are provided. For example, CEO John Mastrototaro holds options for 1,932 shares exercisable at \$750.00, expiring 12/06/2030.
• Related Party Transactions: The Board is responsible for reviewing and approving all material transactions with related persons, which include directors, officers, and large shareholders. Recent preferred stock and warrant purchases by PV Klustr LLC and other investors are disclosed.
• Principal Accountant Fees: Audit fees for professional services, including annual and quarterly review and SEC filing assistance, are detailed. Audit-related fees include due diligence and registration statement review.
• Nasdaq Listing: Shares of common stock are listed on the Nasdaq Capital Market under the symbol “MOVE.”

Potential Price-Sensitive Issues

• Governance and Compliance: The restatement of major governance items, delayed Section 16(a) filings, and insider trading policy changes could be viewed as red flags or improvements, potentially impacting investor confidence and share price.
• Equity Incentive Plan: The approval and expansion of the equity incentive plan may lead to additional stock awards, potentially diluting existing shareholders in the future.
• Anti-Takeover Defense: Anti-takeover provisions and the ability to issue preferred stock may deter hostile takeovers, but can also inhibit shareholder activism or acquisition premiums.
• No Financial Statement Amendments: While no financials are included or restated, the focus on governance and compliance could indicate underlying issues or simply a proactive approach by management.

Exhibit Index (Selected)

Summary for Investors

The amendments in this report focus on governance, executive compensation, insider trading policies, and equity incentives. While there are no changes to financial statements, the governance updates, compliance disclosures, and expanded equity awards are material and could impact investor sentiment and share value. Shareholders should pay close attention to the anti-takeover provisions, the potential for dilution from new stock awards, and the implications of delayed SEC filings by directors.

View Corvex, Inc. Historical chart here